CliffBio
small molecule

DESOXIMETASONE

DESOXIMETASONE

Loss of exclusivity—loss of exclusivity
CompanyLupin →See this company's full patent-cliff portfolio

Drug detail

Brand nameDESOXIMETASONE
Active ingredientDESOXIMETASONE
Strength0.25%
Dosage formSPRAY
RouteTOPICAL
ModalitySmall molecule
FDA approvalMarch 2018
Marketing statusRX

More from Lupin

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.